Article
Divergent effects of target protein stabilisation versus overproduction on PROTAC activity
2026-04-18
Abstract excerpt
Protein degrader drugs such as PROTACs are being advanced as therapeutics targeted against oncogenic proteins. During tumorigenesis, oncogenic proteins can become constitutively activated via mechanisms including gene amplification, which increases protein production, and point mutations, which can extend protein half-life. Few experimental studies have addressed how disease-associated changes in target protein ho...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 070329a4-33a2-5615-9204-4e16f078458f
- DOI
- 10.64898/2026.04.15.718695
